| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |